Cargando…
Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy
BACKGROUND: Immunosuppressant drugs reduce proteinuria and anti-phospholipase A2 receptor autoantibodies (PLA2R-Ab) in primary membranous nephropathy (PMN) with varying success and associated toxicities. This study aimed to evaluate the effect of belimumab on proteinuria and PLA2R-Ab in participants...
Autores principales: | Barrett, Christine, Willcocks, Lisa C, Jones, Rachel B, Tarzi, Ruth M, Henderson, Robert B, Cai, Gengqian, Gisbert, Sophie I, Belson, Alexandra S, Savage, Caroline O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139214/ https://www.ncbi.nlm.nih.gov/pubmed/31243451 http://dx.doi.org/10.1093/ndt/gfz086 |
Ejemplares similares
-
Clinical Efficacy of Routinely Administered Belimumab on Proteinuria and Neuropsychiatric Lupus
por: Plüß, Marlene, et al.
Publicado: (2020) -
Autoantibodies against Phospholipase A(2) Receptor in Korean Patients with Membranous Nephropathy
por: Oh, Yun Jung, et al.
Publicado: (2013) -
The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation
por: Xipell, Marc, et al.
Publicado: (2018) -
Anti-Phospholipase A(2) Receptor Autoantibody: A New Biomarker for Primary Membranous Nephropathy
por: Zhu, Quansheng
Publicado: (2016) -
Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in Idiopathic Membranous Nephropathy
por: Dong, Lei, et al.
Publicado: (2022)